NASDAQ:APVO

Aptevo Therapeutics Inc Earning Date

USA |NASDAQ |USD

APVO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-1.75 $-2.10
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $3.11M $1.46M

Aptevo Therapeutics Inc's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

APVO Earnings Date & History Chart

APVO Earnings & Revenue Forecast

APVO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-1.40 $-1.76 $-1.05
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-5.66 $-5.66 $-5.66
Dec 2022 1 $-5.18 $-5.18 $-5.18

APVO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.40 $-1.22 $-1.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-5.66 $-6.39 $-6.39
Dec 2022 0 / 0 $-5.18 $-5.19 $-5.19

APVO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $4.25M $4.00M $4.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $13.41M $13.00M $13.83M
Dec 2022 2 $17.34M $14.69M $20.00M

APVO Earnings Date & Revenue History

APVO Earnings History

|
Show More
Show More

APVO Revenue History

|
Show More
Show More

Aptevo Therapeutics Inc Next Earnings Date & Report

APVO Aug 2021 (FQ) Earnings Date & Report Preview

APVO's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Aptevo Therapeutics Inc Previous Earnings Dates & Reports

APVO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aptevo Therapeutics Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

APVO's earnings per share (EPS) was $-1.75, beating the consensus analysts forecast of $-1.85 by 5.15%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 6.71%, and higher than the same period a year before (Jun 2020) by -16.67%.

Revenues were $3.11M, better than the forecast of $900.00K by 245.56%, up by 28.46% from the previous quarter , and up by 557.51% from the same period last year.

The company reported a net income of $-7.93M.

Free cash flow for the quarter was $-5.44M , compared to $-7.70M last quarter and $-4.63M a year before.

APVO ended the quarter with $16.86M in total debt, a decrease of -0.24% compared to the previous quarter, and an increase of 490.09% compared to the same quarter a year before.

APVO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aptevo Therapeutics Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

APVO's earnings per share (EPS) was $-5.23, missing the consensus analysts forecast of $-4.56 by 14.69% , and higher than the previous year's EPS (Dec 2019) by -62.27%.

Revenues were $4.31M, better than the forecast of $3.68M by 17.09%, and down by -86.71% from previous year's revenue.

The company reported a net income of $-17.75M.

Aptevo Therapeutics Inc reported a free cash flow of $-29.41M for its fiscal year, compared to $-42.54M a year ago.

The company ended the fiscal year with $10.00M in total debt, a decrease of -56.88% compared to the previous year.